"There's... a glimmer of hope from the recent data that, whilst this variant does still appear to have a significant growth advantage, the magnitude of that advantage seems to have dropped a little bit with the most recent data," Neil Ferguson, an epidemiologist at Imperial College London, told BBC radio.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3hCI127
via IFTTT
0 comments:
Post a Comment